1. Home
  2. OCGN vs FSP Comparison

OCGN vs FSP Comparison

Compare OCGN & FSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • FSP
  • Stock Information
  • Founded
  • OCGN 2013
  • FSP 1981
  • Country
  • OCGN United States
  • FSP United States
  • Employees
  • OCGN N/A
  • FSP N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • FSP Real Estate Investment Trusts
  • Sector
  • OCGN Health Care
  • FSP Real Estate
  • Exchange
  • OCGN Nasdaq
  • FSP Nasdaq
  • Market Cap
  • OCGN 189.6M
  • FSP 159.5M
  • IPO Year
  • OCGN N/A
  • FSP N/A
  • Fundamental
  • Price
  • OCGN $0.67
  • FSP $1.53
  • Analyst Decision
  • OCGN Strong Buy
  • FSP
  • Analyst Count
  • OCGN 3
  • FSP 0
  • Target Price
  • OCGN $6.33
  • FSP N/A
  • AVG Volume (30 Days)
  • OCGN 3.2M
  • FSP 285.2K
  • Earning Date
  • OCGN 05-09-2025
  • FSP 04-29-2025
  • Dividend Yield
  • OCGN N/A
  • FSP 2.65%
  • EPS Growth
  • OCGN N/A
  • FSP N/A
  • EPS
  • OCGN N/A
  • FSP N/A
  • Revenue
  • OCGN $4,522,000.00
  • FSP $115,994,000.00
  • Revenue This Year
  • OCGN N/A
  • FSP $4.36
  • Revenue Next Year
  • OCGN N/A
  • FSP $0.81
  • P/E Ratio
  • OCGN N/A
  • FSP N/A
  • Revenue Growth
  • OCGN N/A
  • FSP N/A
  • 52 Week Low
  • OCGN $0.52
  • FSP $1.36
  • 52 Week High
  • OCGN $2.06
  • FSP $2.21
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 46.49
  • FSP 43.75
  • Support Level
  • OCGN $0.65
  • FSP $1.49
  • Resistance Level
  • OCGN $0.75
  • FSP $1.60
  • Average True Range (ATR)
  • OCGN 0.05
  • FSP 0.07
  • MACD
  • OCGN -0.01
  • FSP 0.01
  • Stochastic Oscillator
  • OCGN 15.38
  • FSP 28.12

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.

Share on Social Networks: